Pharmaceutical

Cancer Research UK and CRIS fund lung cancer vaccine research

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

Mar 26, 2024 - 00:00
Cancer Research UK and CRIS fund lung cancer vaccine research
Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.
Read the original article

Tags:

Previous Article

FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension

Next Article

FDA approves Takeda’s Iclusig for Philadelphia chromosome-positive ALL

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Janssen submits sBLA to FDA for NSCLC combination therapy

Janssen submits sBLA to FDA for NSCLC combination therapy

Aug 28, 2023

STAT+: Data backing prescription digital therapeutics found lacking in rigor, inclusivity

STAT+: Data backing prescription digital therapeutics f...

Nov 7, 2023

AstraZeneca buys Chinese CAR-T biotech Gracell in a $1.2bn deal

AstraZeneca buys Chinese CAR-T biotech Gracell in a $1....

Dec 28, 2023